CML Treated With Bosutinib After Relapse

Clinical trial NCT02445742 · COMPLETED

Trial details

NCT number: NCT02445742
Sponsor: PETHEMA Foundation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloblastic Leukaemia

Start date: 2015-05-01
Primary completion: 2018-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.